Axenfeld-Rieger Syndrome
A spectrum of bilateral anterior segment dysgenesis disorders characterised by posterior embryotoxon, iridogoniodysgenesis, and a 50% lifetime risk of glaucoma. Caused by autosomal dominant mutations in PITX2 or FOXC1, it spans from isolated Axenfeld anomaly to Rieger syndrome with systemic dental, craniofacial, and pituitary anomalies.
Last updated: March 2026
Fig 1 — Anterior Segment View (Axenfeld-Rieger Syndrome)
Fig 2 — Iridocorneal Angle Cross-Section (ARS vs Normal)
A — Posterior Embryotoxon
Anteriorly displaced, thickened Schwalbe line visible as a white ring at the limbus without gonioscopy. Present in ~15% of the normal population as an isolated variant — pathological only when combined with iris strands.
B — Iris Strands (Axenfeld)
Fibrous strands bridging from the peripheral iris surface to the anteriorly displaced Schwalbe line. Represent incomplete regression of fetal mesodermal tissue. Their presence distinguishes ARS from isolated posterior embryotoxon.
C, F — Glaucoma Mechanism
Trabecular meshwork dysgenesis with reduced outflow capacity, compounded by PAS from iris strand contraction. Glaucoma develops in ~50% of ARS patients, often requiring surgical management.
C, D, E — Iris Changes (Rieger)
Iris hypoplasia (thin, lacy stroma), corectopia (displaced pupil), and pseudo-polycoria (full-thickness atrophic holes) characterise the Rieger anomaly end of the spectrum.
Fig 1. Anterior segment comparison of ARS (left) and a normal eye (right). Labels A-F: posterior embryotoxon (A), iris strands bridging to Schwalbe line (B), iris hypoplasia with translucent patches (C), corectopia with temporally displaced pupil (D), pseudo-polycoria (E), and ectropion uveae at the pupil margin (F).
Fig 2. Iridocorneal angle cross-section comparing ARS (left) with a normal open angle (right). ARS angle shows: prominent displaced Schwalbe line (A), iris strands spanning from iris periphery to Schwalbe line (B), dysgenetic trabecular meshwork with reduced outflow (C), thin hypoplastic iris (D), pseudo-polycoria hole (E), and peripheral anterior synechiae (F). Normal angle shows flush Schwalbe line, open TM, and full-thickness iris.
Axenfeld-Rieger syndrome (ARS) is a spectrum of bilateral anterior segment dysgenesis disorders caused by incomplete differentiation of neural crest-derived anterior segment tissues. The spectrum ranges from Axenfeld anomaly (isolated posterior embryotoxon with iris strands, without iris hypoplasia) to Rieger anomaly (posterior embryotoxon with iris hypoplasia, corectopia, and pseudo-polycoria) to Rieger syndrome, which adds characteristic systemic anomalies including dental hypodontia, maxillary hypoplasia, redundant periumbilical skin, and posterior pituitary abnormalities leading to growth hormone deficiency.
ARS is inherited in an autosomal dominant pattern with mutations identified most frequently in the PITX2 gene (chromosome 4q25, ~40% of familial cases) and FOXC1 gene (chromosome 6p25, ~15% of familial cases). Both encode transcription factors critical for neural crest cell migration and anterior segment differentiation. Approximately 50% of ARS patients develop glaucoma, typically in childhood or early adulthood (juvenile-onset open-angle or synechial closure), requiring lifelong monitoring and often surgical management. All patients with suspected ARS require prompt ophthalmological assessment, genetic counselling, and systemic evaluation including dental, endocrine, and cardiac assessment.
PITX2 Gene Mutations (Chromosome 4q25)
PITX2 (Paired-like homeodomain transcription factor 2) is the most commonly mutated gene, accounting for approximately 40% of familial ARS cases. PITX2 is expressed in neural crest cells migrating into the periocular mesenchyme and plays essential roles in anterior segment formation, including trabecular meshwork, iris stroma, and corneal endothelium. Haploinsufficiency (loss of one functional allele) results in incomplete anterior segment differentiation — a dosage-sensitive developmental mechanism. PITX2 mutations also cause Iridogoniodysgenesis Syndrome (IGDS) and Axenfeld-Rieger type 1.
FOXC1 Gene Mutations (Chromosome 6p25)
FOXC1 (Forkhead box C1) mutations account for approximately 15% of familial ARS. FOXC1 is a transcription factor expressed in neural crest cells and required for trabecular meshwork and corneal endothelial development. Haploinsufficiency of FOXC1 results in a phenotype overlapping with PITX2-associated ARS. FOXC1 duplications may also produce an ARS phenotype, illustrating dosage sensitivity in both directions. Axenfeld-Rieger type 3 is associated with FOXC1 mutations.
Sporadic and Other Genetic Causes
Approximately 40-45% of ARS cases have no identified PITX2 or FOXC1 mutation. Other chromosomal loci implicated include 13q14 (Axenfeld-Rieger type 2). Sporadic de novo mutations account for a proportion of cases without family history. Variable expressivity and incomplete penetrance within families mean that not all carriers of a mutation will develop clinically evident disease.
- Neural crest cell migration (embryological basis): During embryonic development, neural crest cells migrate from the dorsal neural tube into the periocular region, differentiating into trabecular meshwork cells, corneal endothelium, iris stroma, and other anterior segment structures. PITX2 and FOXC1 are required transcription factors that drive appropriate differentiation of these neural crest-derived cells.
- Haploinsufficiency of PITX2/FOXC1: Loss of one functional allele of PITX2 or FOXC1 reduces transcription factor activity below the threshold required for complete anterior segment differentiation. The resulting hypomorphic phenotype means these genes are dosage-sensitive — both deletion and duplication produce pathological outcomes.
- Incomplete regression of anterior segment mesodermal tissue: In normal development, the anterior fetal mesodermal tissue that covers the trabecular meshwork and angle regresses completely. In ARS, this regression is incomplete, leaving residual tissue forming iris strands that bridge the iris periphery to the anteriorly displaced Schwalbe line (posterior embryotoxon).
- Trabecular meshwork dysgenesis: Incomplete differentiation of trabecular meshwork cells results in dysplastic trabeculae with reduced aqueous outflow capacity. This trabecular dysfunction, combined with residual mesodermal tissue covering the angle, produces the elevated aqueous outflow resistance responsible for glaucoma in approximately 50% of cases.
- Iris changes (Rieger anomaly): Iris stroma is hypoplastic (thin, lacy) from incomplete differentiation of iris stromal cells. The pupillary ruff (collarette) may be absent. Corectopia results from asymmetric fibrovascular membrane contraction pulling the pupil. Pseudo-polycoria (apparent multiple pupils) represents full-thickness atrophic holes in a hypoplastic iris stroma.
- Systemic manifestations (Rieger syndrome): PITX2 is also expressed in dental primordia, maxillary mesenchyme, and pituitary gland. Haploinsufficiency causes incomplete dental development (hypodontia, microdontia), maxillary hypoplasia (midface recession), redundant periumbilical skin from umbilical failure of regression, and posterior pituitary hypoplasia leading to growth hormone deficiency.
ARS is a spectrum — all share the same genetic basis but differ in expressivity.
| Entity | Ocular Features | Systemic Features | Glaucoma Risk |
|---|---|---|---|
| Axenfeld Anomaly | Posterior embryotoxon + iris strands to Schwalbe line; NO iris hypoplasia | None | ~50% |
| Rieger Anomaly | Posterior embryotoxon + iris strands + iris hypoplasia, corectopia, pseudo-polycoria | None | ~50% |
| Rieger Syndrome | Same as Rieger anomaly | Dental anomalies, maxillary hypoplasia, redundant periumbilical skin, GH deficiency, cardiac defects | ~50% |
| Peter Anomaly (overlap) | Central corneal opacity with iridocorneal adhesions; leukoma; may co-occur with ARS features | Variable | High |
- Family history of ARS: Autosomal dominant inheritance; offspring of an affected parent have a 50% risk of inheriting the mutation; however, variable expressivity means phenotypic severity cannot be predicted
- De novo PITX2 or FOXC1 mutation: New mutations in PITX2 or FOXC1 without family history; accounts for a proportion of sporadic cases
- Both sexes equally affected: Autosomal dominant inheritance; no sex predilection
- Bilateral presentation: ARS is always (or nearly always) bilateral, though asymmetric in severity; the more severely affected eye tends to be at higher glaucoma risk
- Expressivity modifiers: Environmental factors and modifier genes may influence severity of the ocular and systemic phenotype, explaining variable expression within families carrying the same mutation
Slit-Lamp Findings
- Posterior embryotoxon: Anteriorly displaced and thickened Schwalbe line visible as a white, prominent, opaque ring at the peripheral corneal limbus; visible without gonioscopy; present in ~15% of the normal population as an isolated non-pathological variant (significant only when combined with iris strands)
- Iris hypoplasia: Thin, lacy, translucent iris stroma; iris crypts may be absent or exaggerated; sphincter muscle may be visible through the thin stroma; the pupillary ruff (collarette) is often absent or atrophic
- Corectopia: Eccentric, displaced pupil; typically displaced toward a region of iris strand/PAS formation; less severe than in ICE syndrome and does not progress to iris holes
- Pseudo-polycoria: Full-thickness atrophic holes in a hypoplastic iris stroma giving the appearance of multiple pupils; distinguished from true polycoria (multiple true pupils with sphincters) by absence of reactive constriction of accessory openings
- Ectropion uveae: Posterior iris pigment epithelium visible on the anterior iris surface at the pupillary margin; may be congenital in ARS
Gonioscopy
- Iris strands (Axenfeld strands): Fibrous strands bridging from the peripheral iris surface to the anteriorly displaced Schwalbe line; strands may be fine (thread-like) to broad (sheet-like); their presence distinguishes pathological posterior embryotoxon from the common normal variant
- Trabecular dysgenesis: poorly developed, dysmorphic trabecular beams; reduced aqueous outflow capacity
- Angle grade varies; may be open (trabecular dysfunction) or partially closed (synechial component)
- Peripheral anterior synechiae: broad-based PAS from iris strand contraction
Glaucoma-Related Signs
- Glaucomatous optic nerve cupping: elevated cup-to-disc ratio; inferior notching; RNFL defects on OCT
- Elevated IOP: often juvenile onset; may present acutely in childhood or slowly progress in adulthood
- In children: corneal enlargement (buphthalmos), Haab striae, corneal oedema from elevated IOP in the first year of life
- Mostly asymptomatic in early childhood: ARS is usually detected incidentally during routine screening, family member evaluation, or investigation of systemic features (dental anomalies) rather than from ocular symptoms
- Photophobia: Enlarged, ectopic, or misshapen pupil alters light regulation; iris hypoplasia allows excess light entry
- Blurred vision: From amblyopia (if anisometropia, strabismus, or corneal opacity present), or from glaucomatous optic nerve damage in untreated cases
- Monocular diplopia or glare: Pseudo-polycoria (accessory iris holes) creates additional light entry paths, causing ghost images
- Pain and halos: Acute IOP elevation from progressive angle involvement; may present as acute glaucoma in adulthood
- Cosmetic concern: Iris hypoplasia, corectopia, and pseudo-polycoria may be noticed and cause social concern, particularly in school-aged children
Glaucoma (~50% Lifetime Risk)
The most significant ocular complication. May be juvenile-onset (IOP elevated in first two decades, requiring early surgical management) or adult-onset (presenting in the third to fifth decades). The mechanism is primarily trabecular meshwork dysgenesis with reduced outflow facility, compounded by synechial angle closure from iris strand contraction. Glaucoma in ARS often requires surgical management (goniotomy, trabeculotomy, or tube shunt); medical therapy alone may be insufficient for long-term IOP control.
Amblyopia
Risk from uncorrected refractive error (particularly anisometropia), strabismus, or corneal opacity overlapping with the visual axis. Requires aggressive management in the amblyogenic period (patching, refractive correction) to prevent irreversible visual impairment.
Strabismus
May be consequent to amblyopia or independent. Requires orthoptic assessment and management alongside other ocular complications.
Peter Anomaly Overlap
In cases with central corneal opacity (leukoma) from iridocorneal adhesion (Peter anomaly variant), visual prognosis is more guarded and corneal transplantation may be required.
- Dental anomalies (~80% of Rieger syndrome): Hypodontia (reduced number of teeth), oligodontia (severe reduction), microdontia (small teeth), and abnormal tooth shape; maxillary hypoplasia causes midface recession and anterior open bite; dental X-rays essential for evaluation
- Maxillary hypoplasia: Flat midface, relative prognathism, broad nasal bridge; cosmetically apparent; may require maxillofacial surgical correction
- Redundant periumbilical skin: Characteristic finding in Rieger syndrome; failure of normal umbilical skin regression in the neonatal period leaving a flap of excess skin around the umbilicus; asymptomatic but diagnostically useful
- Growth hormone deficiency: Posterior pituitary hypoplasia from PITX2 haploinsufficiency in pituitary development; presents as growth retardation, short stature; responds to GH supplementation if diagnosed early; paediatric endocrinology referral essential
- Cardiac septal defects: Atrial or ventricular septal defects reported in a minority of Rieger syndrome cases; cardiac echo if congenital heart disease suspected
- Hypospadias: Abnormal urethral positioning reported in some male patients with Rieger syndrome; urological evaluation if suspected
- Cerebral and pituitary MRI: Empty sella, corpus callosum abnormalities reported in some ARS patients; neurological imaging if developmental concerns arise
- Slit-lamp biomicroscopy: Identify posterior embryotoxon (visible as white peripheral ring at limbus without gonioscopy), iris hypoplasia, corectopia, pseudo-polycoria, ectropion uveae; document with anterior segment photography
- Gonioscopy: Essential to visualise iris strands bridging to Schwalbe line (distinguishing pathological from isolated posterior embryotoxon), assess angle grade, identify trabecular dysgenesis and PAS; perform under ophthalmology supervision
- IOP monitoring: At every visit from birth/diagnosis; elevated IOP is the primary warning sign for glaucoma development; use age-appropriate method in children (Perkins tonometer for infants, iCare rebound tonometer)
- Optic nerve assessment: Serial fundus photography and OCT optic nerve head imaging; Humphrey visual fields when age-appropriate (reliable from approximately 6 years); establish baseline at diagnosis
- Anterior segment OCT (AS-OCT): Documents angle morphology, iris configuration, and PAS; non-contact; useful for monitoring in children who cannot cooperate with gonioscopy
- Genetic testing (PITX2 and FOXC1 sequencing): Diagnostic and prognostic value; enables family screening of at-risk relatives; gene panel testing available at genetic centres
- Systemic evaluation: Dental X-ray panorex (hypodontia assessment); endocrine evaluation — IGF-1, IGFBP-3, growth velocity, bone age X-ray if growth concerns; cardiac echocardiography if congenital heart disease suspected
- Family screening: Examination of first-degree relatives for posterior embryotoxon and iris changes; genetic counselling for affected families
- Paediatric ophthalmology and multidisciplinary team referral: Involves ophthalmology, clinical genetics, paediatric endocrinology, paediatric dentistry/maxillofacial surgery, and paediatrics
1. Glaucoma — Medical Management
Topical hypotensives as first-line IOP management: beta-blockers (timolol 0.25% bd in children, 0.5% in adults), carbonic anhydrase inhibitors (dorzolamide, brinzolamide), and prostaglandin analogues (latanoprost — with caution in children due to limited safety data). Systemic acetazolamide may be required for acute IOP elevation in children. Medical therapy alone is often insufficient long-term in juvenile-onset ARS glaucoma.
2. Glaucoma — Surgical Management
- Goniotomy or trabeculotomy: Preferred initial surgical intervention in children with ARS glaucoma; incises the trabecular meshwork to improve aqueous outflow; success rates are moderate (50–70%); may need to be repeated
- Trabeculectomy with antimetabolite (MMC): For refractory glaucoma in older children and adults; higher risk of bleb failure and infection than in POAG
- Glaucoma drainage devices (tube shunts): Ahmed or Baerveldt valve for refractory cases; particularly useful after failed trabeculectomy
- Cyclophotocoagulation: For refractory end-stage glaucoma where other surgical options have failed
3. Amblyopia and Refractive Management
Prescribe refractive correction promptly; prescribe glasses at the earliest opportunity to prevent or treat amblyopia. Occlusion therapy (patching the better-seeing eye) for established amblyopia. Strabismus surgery if alignment deviation does not resolve with refractive correction alone. Regular refraction every 6 months in children under 8 years.
4. Anterior Segment Dysgenesis — No Reversal
No pharmacological or surgical treatment reverses the congenital anterior segment anomalies (iris hypoplasia, posterior embryotoxon, iris strands). Management is directed at treating glaucoma and optimising visual rehabilitation through refractive correction and amblyopia management.
5. Systemic Management
Growth hormone deficiency: recombinant GH supplementation under paediatric endocrinology supervision — excellent response if initiated early. Dental anomalies: prosthodontic management, dental implants, orthodontics — referral to paediatric dentistry and oral maxillofacial surgery. Maxillary hypoplasia: Le Fort osteotomy in selected adult patients with significant midface deficiency. Genetic counselling for affected families and reproductive decision-making support.
Singapore Optometry Scope Note: Optometrists must screen for glaucoma at every visit in all ARS patients — IOP measurement and optic nerve assessment are mandatory at each encounter. Refer all newly suspected or confirmed ARS patients to ophthalmology promptly for gonioscopy, IOP assessment, and genetic evaluation. Manage refractive error and amblyopia aggressively within optometric scope — early spectacle correction and patching can prevent irreversible amblyopia. Document posterior embryotoxon photographically and note whether iris strands are visible (this distinguishes pathological ARS from isolated posterior embryotoxon, which is common in the general population). If growth delay is reported in a child with ARS features, coordinate referral to paediatric endocrinology for GH assessment. First-degree family members of confirmed ARS patients should be offered screening examinations.
- Visual prognosis: Depends primarily on glaucoma control; patients with well-controlled IOP from childhood who avoid significant optic nerve damage have an excellent long-term visual prognosis; amblyopia successfully treated early has good outcomes
- Glaucoma control: Early-onset glaucoma in children with ARS is particularly challenging to manage and often requires multiple surgical procedures over a lifetime; surgical success rates decline with each subsequent procedure
- Systemic prognosis: Growth hormone deficiency responds well to recombinant GH supplementation if initiated before growth plate closure; dental and maxillofacial anomalies are surgically manageable but require long-term specialist care; cardiac defects are treatable with standard paediatric cardiac surgery
- Genetic prognosis: 50% risk of transmission to offspring with AD inheritance; variable expressivity means severity cannot be predicted in advance; genetic counselling is an important component of long-term care
- Lifelong surveillance required: ARS is a lifelong condition requiring indefinite ophthalmological follow-up regardless of current visual status; glaucoma can develop or progress at any age
| Condition | Key Differentiator from ARS |
|---|---|
| Isolated posterior embryotoxon | No iris strands on gonioscopy; no iris hypoplasia; common normal variant (~15% of population); no glaucoma risk in isolation; no systemic associations |
| Aniridia | Near-total iris absence (rudimentary iris); PAX6 gene mutation; foveal hypoplasia; nystagmus; no posterior embryotoxon; no iris strands; Wilms tumour risk (WAGR syndrome) |
| ICE syndrome | Unilateral; acquired; young-to-middle-aged women; ICE cells on specular microscopy; no iris strands; no systemic associations; no genetic inheritance |
| Peter anomaly | Central corneal leukoma with iridocorneal adhesion; may overlap with ARS; central rather than peripheral; often more severe visual impairment from corneal opacity |
| Congenital glaucoma (primary) | CYP1B1 mutations; buphthalmos, Haab striae, corneal clouding; no iris strands or posterior embryotoxon; no systemic associations; trabecular dysgenesis without iris involvement |
| Iridocorneal dysgenesis / Posterior polymorphous dystrophy | Band/vesicular corneal lesions; iris changes milder; bilateral; hereditary; different specular microscopy pattern; no posterior embryotoxon |
- Shields MB. Textbook of Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1998. Chapter on anterior segment dysgenesis.
- Semina EV, Reiter R, Leysens NJ, et al. Cloning and characterisation of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet. 1996;14(4):392–399.
- Nishimura DY, Swiderski RE, Alward WL, et al. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet. 1998;19(2):140–147.
- Alward WL. Axenfeld-Rieger syndrome in the age of molecular genetics. Am J Ophthalmol. 2000;130(1):107–115.
- Shields MB, Buckley E, Klintworth GK, Thresher R. Axenfeld-Rieger syndrome. A spectrum of developmental disorders. Surv Ophthalmol. 1985;29(6):387–409.
- Strungaru MH, Dinu I, Walter MA. Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations. Invest Ophthalmol Vis Sci. 2007;48(1):228–237.
- Lines MA, Kozlowski K, Walter MA. Molecular genetics of Axenfeld-Rieger malformations. Hum Mol Genet. 2002;11(10):1177–1184.